Long-term risk of recurrence in surgically treated renal cell carcinoma: A post hoc analysis of the Eastern Cooperative Oncology Group—American College of Radiology Imaging Network E2805 Trial Cohort

European Urology Nov 18, 2019

Jamil ML, Keeley J, Sood A, et al. - A post hoc analysis of individuals within the Eastern Cooperative Oncology Group—American College of Radiology Imaging Network (ECOG-ACRIN) E2805 trial cohort was conducted in order to examine the long-term risk of recurrence in surgically treated renal cell carcinoma (RCC) to ascertain the utility of long-term surveillance. Of the 1,943 individuals involved in the original cohort, 730 acquired recurrence. For individuals at 0, 12, 24, 36, 48, and 60 mo from surgery, the 36-mo cumulative incidences of recurrence were 31%, 26%, 19%, 16%, 19%, and 20%, respectively. At 0 mo from surgery, independent predictors of recurrence were age, pathological T3/4 stage and, N1/2 stage, and Fuhrman grades 3 and 4, nonetheless, this was not observed at 60 mo after surgery. Findings establish that surveillance imaging should be done beyond 5 yr subsequent to surgical resection of intermediate- to high-risk RCC.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay